Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Total Debt (2020 - 2025)

GoHealth (GOCO) has disclosed Total Debt for 6 consecutive years, with $636.7 million as the latest value for Q4 2025.

  • Quarterly Total Debt rose 30.65% to $636.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $636.7 million through Dec 2025, up 30.65% year-over-year, with the annual reading at $636.7 million for FY2025, 30.65% up from the prior year.
  • Total Debt hit $636.7 million in Q4 2025 for GoHealth, up from $581.8 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $670.4 million in Q4 2021 to a low of $400.2 million in Q1 2021.
  • Historically, Total Debt has averaged $530.8 million across 5 years, with a median of $497.3 million in 2023.
  • Biggest five-year swings in Total Debt: soared 67.36% in 2021 and later fell 25.64% in 2023.
  • Year by year, Total Debt stood at $670.4 million in 2021, then fell by 23.91% to $510.1 million in 2022, then fell by 2.43% to $497.7 million in 2023, then fell by 2.08% to $487.4 million in 2024, then soared by 30.65% to $636.7 million in 2025.
  • Business Quant data shows Total Debt for GOCO at $636.7 million in Q4 2025, $581.8 million in Q3 2025, and $560.0 million in Q2 2025.